Literature DB >> 26251266

[Cerebral venous thrombosis: Case report and clinical procedures].

A Koch1, B Schick2.   

Abstract

Cerebral venous and dural sinuses thrombosis (CVT) is a relatively rare but very serious disease, because of the risk of mortality. Cardinal symptoms are usually severe sudden-onset localized headaches, which may or not be accompanied by focal or generalized neurological deficits or seizures. It is particularly important to consider CVT in the presence of underlying prothrombotic conditions (genetically predisposed or acquired defects of the coagulation system) or well-known risk factors (hormonal contraception, pregnancy, puerperium, smoker status). Based on clinical findings, diagnosis is established using neuroimaging (MRI and MR venography, CT and CT venography) and D-dimer measurement. In the case of early diagnosis and onset of antithrombotic treatment, the prognosis is good. Otherwise there is a high risk of irreversible neurological deficits or even mortality. In daily clinical routine, where many patients present with similar or unspecific symptoms-most of which are harmless-it is thus particularly important that CVT be considered in the differential diagnosis.

Entities:  

Keywords:  D-dimer; Headache; Neuroimaging; Risk factors; Seizures

Mesh:

Substances:

Year:  2016        PMID: 26251266     DOI: 10.1007/s00106-015-0044-3

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  10 in total

Review 1.  D-dimer testing in the diagnosis of cerebral vein thrombosis: a systematic review and a meta-analysis of the literature.

Authors:  F Dentali; A Squizzato; C Marchesi; M Bonzini; J M Ferro; W Ageno
Journal:  J Thromb Haemost       Date:  2012-04       Impact factor: 5.824

Review 2.  Thrombosis of the cerebral veins and sinuses.

Authors:  Jan Stam
Journal:  N Engl J Med       Date:  2005-04-28       Impact factor: 91.245

Review 3.  Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association.

Authors:  Gustavo Saposnik; Fernando Barinagarrementeria; Robert D Brown; Cheryl D Bushnell; Brett Cucchiara; Mary Cushman; Gabrielle deVeber; Jose M Ferro; Fong Y Tsai
Journal:  Stroke       Date:  2011-02-03       Impact factor: 7.914

4.  Isolated intracranial hypertension as the only sign of cerebral venous thrombosis.

Authors:  V Biousse; A Ameri; M G Bousser
Journal:  Neurology       Date:  1999-10-22       Impact factor: 9.910

5.  Thunderclap headache as first symptom of cerebral venous sinus thrombosis. CVST Study Group.

Authors:  S F de Bruijn; J Stam; L J Kappelle
Journal:  Lancet       Date:  1996-12-14       Impact factor: 79.321

6.  The incidence of cerebral venous thrombosis: a cross-sectional study.

Authors:  Jonathan M Coutinho; Susanna M Zuurbier; Majid Aramideh; Jan Stam
Journal:  Stroke       Date:  2012-09-20       Impact factor: 7.914

7.  Cerebral sinovenous thrombosis in children.

Authors:  G deVeber; M Andrew; C Adams; B Bjornson; F Booth; D J Buckley; C S Camfield; M David; P Humphreys; P Langevin; E A MacDonald; J Gillett; B Meaney; M Shevell; D B Sinclair; J Yager
Journal:  N Engl J Med       Date:  2001-08-09       Impact factor: 91.245

8.  EFNS guideline on the treatment of cerebral venous and sinus thrombosis in adult patients.

Authors:  K Einhäupl; J Stam; M-G Bousser; S F T M De Bruijn; J M Ferro; I Martinelli; F Masuhr
Journal:  Eur J Neurol       Date:  2010-10       Impact factor: 6.089

9.  Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT).

Authors:  José M Ferro; Patrícia Canhão; Jan Stam; Marie-Germaine Bousser; Fernando Barinagarrementeria
Journal:  Stroke       Date:  2004-02-19       Impact factor: 7.914

10.  Isolated lateral sinus thrombosis: a series of 62 patients.

Authors:  Mariem Damak; Isabelle Crassard; Valérie Wolff; Marie-Germaine Bousser
Journal:  Stroke       Date:  2008-12-31       Impact factor: 7.914

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.